Around two thirds (61%) of life science investor respondents look for manag...

Jose Lozano, President and Chief Executive Officer at Choose New Jersey, ou...

With winter in full swing, no doubt many of us will have come down with flu...

As new technologies look to play an ever-increasing role in addressing heal...

On 25 October 2018 the Court of Justice of the European Union (CJEU) handed...

How are established investors working to foster innovation in today’s biote...

On 5 February 2019, a panel of leading medtech investors will open the 5th ...

In October 2018, German medical device company Protembis closed an oversubs...

On 5-6 February 2019, international life sciences investors, C-level execut...

Jose Lozano, President and Chief Executive Officer at Choose New Jersey, di...

The Opinion of Advocate General Saugmandsgaard Øe in Abraxis Bioscience (Ca...

At a roundtable event in London in September 2018, CMS assembled a selectio...